Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Kite Pharma Inc.
*MAILING ADDRESS
2400 Broadway
*CITY
Santa Monica
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
90404
PHONE
310-824-9999
*EMAIL ADDRESS
XXXX
WEBSITE ADDRESS
www.kitepharma.com
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations for immunotherapy, including cell therapy and gene
therapy; biological preparations for the treatment of cancer
photograph of Applicant's product displaying the mark in use
WEBPAGE URL
None Provided
WEBPAGE DATE OF ACCESS
None Provided
ATTORNEY INFORMATION
NAME
Cynthia Smuzynska
ATTORNEY DOCKET NUMBER
08571-US-NF2
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Gilead Sciences, Inc.
STREET
333 Lakeside Drive
CITY
Foster City
STATE
California
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
94404
PHONE
650-574-3000
FAX
650-522-5575
EMAIL ADDRESS
trademarks@gilead.com
OTHER APPOINTED ATTORNEY
Gretchen R. Stroud; Lori Mayall; Jack Wessel; Shelley Lai; Peter Colosi
CORRESPONDENCE INFORMATION
NAME
Cynthia Smuzynska
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
trademarks@gilead.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
TMTeam@gilead.com
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
1
APPLICATION FOR REGISTRATION PER CLASS
350
*TOTAL FEES DUE
350
*TOTAL FEES PAID
350
SIGNATURE INFORMATION
SIGNATURE
/cynthia smuzynska/
SIGNATORY'S NAME
Cynthia Smuzynska
SIGNATORY'S POSITION
Senior Counsel, IP
SIGNATORY'S PHONE NUMBER
650-574-3000
DATE SIGNED
03/29/2022
SIGNATURE METHOD
Sent to third party for signature
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:97335737
Filing Date:03/29/2022
To the Commissioner for Trademarks:
MARK: T-CELL FACTORY (Standard Characters, see mark)
The literal element of the mark consists of T-CELL FACTORY. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Kite Pharma Inc., a corporation of Delaware, having an address of
2400 Broadway
Santa Monica, California 90404
United States
310-824-9999(phone)
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations for immunotherapy, including cell therapy and gene therapy; biological
preparations for the treatment of cancer
In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 02/28/2022, and first used in
commerce at least as early as 02/28/2022, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any
item in the class of listed goods/services, consisting of a(n) photograph of Applicant's product displaying the mark in use. Specimen File1
Webpage URL: None Provided
Webpage Date of Access: None Provided
For informational purposes only, applicant's website address is: www.kitepharma.com
The owner's/holder's proposed attorney information: Cynthia Smuzynska. Other appointed attorneys are Gretchen R. Stroud; Lori Mayall; Jack Wessel; Shelley Lai; Peter Colosi. Cynthia Smuzynska of
Gilead Sciences, Inc., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
333 Lakeside Drive
Foster City, California 94404
United States
650-574-3000(phone)
650-522-5575(fax)
trademarks@gilead.com
The docket/reference number is 08571-US-NF2.
Cynthia Smuzynska submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /cynthia smuzynska/ Date: 03/29/2022
Signatory's Name: Cynthia Smuzynska
Signatory's Position: Senior Counsel, IP
Signatory's Phone Number: 650-574-3000
Signature method: Sent to third party for signature
Payment Sale Number: 97335737
Payment Accounting Date: 03/29/2022
Serial Number: 97335737
Internet Transmission Date: Tue Mar 29 12:08:07 ET 2022
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XX-202203291208074
28687-97335737-8207fbeb814df975aa112cd79
5c2ef87eab5964e1fb96bc8dca1ecd363c7787f-
DA-08060217-20220328201131184733